20102019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 31 Article
  • 2 Review article
  • 1 Editorial
  • 1 Comment/Letter to the editor

Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

Dreger, P., Michallet, M., Bosman, P., Dietrich, S., Sobh, M., Boumendil, A., Nagler, A., Scheid, C., Cornelissen, J., Niederwieser, D., Mueller, L., Vandenberghe, E., Scortechini, I., Schoemans, H., Andersen, N. S., Finke, J., Russo, D., Ljungman, P., Passweg, J., van Gelder, M. & 13 others, Durakovic, N., Labussiere-Wallet, H., Berg, T., Wulf, G., Bethge, W., Bunjes, D., Stilgenbauer, S., Canepari, M. E., Schaap, M., Fox, C. P., Kroeger, N., Montoto, S. & Schetelig, J., Jan 2019, In : Bone Marrow Transplantation. 54, 1, p. 44-52 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia

Schetelig, J., de Wreede, L. C., van Gelder, M., Koster, L., Finke, J., Niederwieser, D., Beelen, D., Mufti, G. J., Platzbecker, U., Ganser, A., Heidenreich, S., Maertens, J., Socie, G., Brecht, A., Stelljes, M., Kobbe, G., Volin, L., Nagler, A., Vitek, A., Luft, T. & 4 others, Ljungman, P., Yakoub-Agha, I., Robin, M. & Kroeger, N., Mar 2019, In : Leukemia. 33, 3, p. 686-695 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Reduced intensity conditioning regimens including alkylating chemotherapy do not alter survival outcomes after allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia compared to low-intensity non-myeloablative conditioning

Andersen, N. S., Bornhaeuser, M., Gramatzki, M., Dreger, P., Vitek, A., Karas, M., Michallet, M., Moreno, C., van Gelder, M., Henseler, A., de Wreede, L. C., Schoenland, S., Kroeger, N., Schetelig, J. & CLL subcomm Chronic, Nov 2019, In : Journal of Cancer Research and Clinical Oncology. 145, 11, p. 2823-2834 12 p.

Research output: Contribution to journalArticleAcademicpeer-review

Clinical Practice Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia (CLL) in The Netherlands

Kersting, S., Neppelenbroek, S. I. M., Visser, H. P. J., van Gelder, M., Levin, M-D., Mous, R., Posthuma, W., van der Straaten, H. M. & Kater, A. P., 1 Jan 2018, In : Clinical Lymphoma Myeloma & Leukemia. 18, 1, p. 52-57 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies

Dreger, P., Ghia, P., Schetelig, J., van Gelder, M., Kimby, E., Michallet, M., Moreno, C., Robak, T., Stilgenbauer, S., Montserrat, E. & ERIC; European Soc Blood Marrow, 30 Aug 2018, In : Blood. 132, 9, p. 892-902 11 p.

Research output: Contribution to journalArticleAcademicpeer-review